Firm Secures Defense Verdict for Novartis in First Bellwether Aredia/Zometa Jury Trial
- Case
- Pharmaceutical & Medical Device
- Products Liability & Toxic Torts
- October 22, 2010
After two hours of deliberation, a New Brunswick, New Jersey jury returned a 7-2 verdict in favor of Novartis Pharmaceuticals Corporation in a ten-day trial involving Aredia and Zometa, bisphosphonate drugs given to people whose cancer…